Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Int J Pharm ; 349(1-2): 206-11, 2008 Feb 12.
Artículo en Inglés | MEDLINE | ID: mdl-17766068

RESUMEN

The objective of this study was to prepare sodium nonivamide acetate (SNA) microemulsion for topical administration. Microemulsions consisted of a mixed surfactant of Tween 80 and Span 20 as surfactant, ethanol as cosurfactant, isopropyl myristate (IPM) as an oil phase and water as an external phase. The effect of composition of microemulsion including the ratio of oil phase/surfactant/aqueous phase, various cosurfactant and polymer on the character and permeability of microemulsion were evaluated. The mean droplet size of SNA microemulsions ranged from 64 to 208 nm. Microemulsions showed potent enhancement effect for SNA transdermal delivery by a 3.7-7.1-fold increase when compared with the control group. Microemulsion containing ethanol as cosurfactant had the highest enhancement effect. With incorporated polymer, the viscosity of microemulsions increased resulting in the decrease in penetration rate of SNA. However, the permeability of SNA delivered from microemulsion was higher than SNA from volatile vehicles (pH 4.2 buffer containing 25% ethanol) reported in an earlier study, therefore microemulsions could be an effective vehicle for topical delivery of SNA.


Asunto(s)
Capsaicina/análogos & derivados , Administración Cutánea , Animales , Capsaicina/administración & dosificación , Conductividad Eléctrica , Emulsiones , Técnicas In Vitro , Tamaño de la Partícula , Vehículos Farmacéuticos , Ratas , Absorción Cutánea , Tensoactivos , Viscosidad
2.
Int J Pharm ; 338(1-2): 48-54, 2007 Jun 29.
Artículo en Inglés | MEDLINE | ID: mdl-17360134

RESUMEN

The influences of a combination of different mechanisms of penetration enhancers on the penetration absorption properties of meloxicam sodium formulations through rat skin were investigated using response surface methodology. A uniform design was applied to prepare model formulations systematically that were composed of four independent variables: the content of ethanol (x(1)), propylene glycol (x(2)), menthol (x(3)), and azone (x(4)). The penetration rate (flux) of meloxicam sodium gel through rat skin was chosen as the response which had to be higher than 400microg/hcm(2) the required flux of meloxicam gel to maintain a therapeutic concentration. The result showed optimal formulation could be obtained from this response surface methodology. Menthol had the greatest potential influence on the penetration absorption of meloxicam sodium, followed by azone, ethanol and PG, respectively. By in vivo study, meloxicam could be determined 1h after topical administration and reached steady-state concentration at about 12h. The bioavailability (%) of the optimal meloxicam sodium gel was about 50.1%.


Asunto(s)
Tiazinas/administración & dosificación , Tiazoles/administración & dosificación , Absorción , Animales , Química Farmacéutica , Geles , Meloxicam , Permeabilidad , Ratas , Ratas Wistar , Piel/metabolismo , Solubilidad , Tiazinas/química , Tiazoles/química
3.
Int J Pharm ; 339(1-2): 47-51, 2007 Jul 18.
Artículo en Inglés | MEDLINE | ID: mdl-17382500

RESUMEN

The purpose of the present study was to design an optimal ketoprofen gel with appropriate penetration rate, shortened lag time and acceptable skin irritation. The combination of different mechanism enhancers including nonivamide, menthol and ethanol were used as multi-enhancers for producing a synergistic enhancement effect and reducing the skin irritation via diminishing the used amount of enhancers. The central composite design was applied to prepare a systemic formulation. The penetration rate (PR), lag time (LT) and skin irritation score (TIS) of a commercial product (Formax plus gel containing 3% ketoprofen) were determined by in vivo study and used as a criterion for designed formulations. The PR, LT and TIS of commercial product were 462.2+/-162.5 microg/h, 0.6+/-0.1 h and 12.7+/-0.6, respectively. Among these designed experimental formulations, four formulations including F07 (code: -1/+1/-1), F11 (code: +1/+1/-1), F13 (code: 0/0/-1.732) and F14 (code: 0/+1.732/0), their PR was not smaller and LT and TIS were not greater than that of commercial product, indicating that these experimental ketoprofen gels could be used in the clinical situation.


Asunto(s)
Cetoprofeno/química , Animales , Química Farmacéutica , Geles , Cetoprofeno/farmacocinética , Masculino , Ratas , Ratas Wistar , Pruebas de Irritación de la Piel
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...